Advancing New Healthcare Solutions Through Collaboration

To accelerate development of a potential novel coronavirus vaccine.

The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.

Never before has it been more important to accelerate the impact of innovation. We remain on the front lines of this health crisis, bringing our full resources and minds to combat it. In line with this purpose, Johnson & Johnson Innovation will be engaging fully in BIO-Europe Spring, the largest life science partnering conference to be  delivered digitally, and we will continue making new connections virtually with innovators and entrepreneurs to accelerate lifesaving solutions for patients & consumers. Learn more about how to connect with us.

Find out all you need to know on how Johnson  & Johnson is responding to the coronavirus global pandemic